DR. RAKESH ROHATGI M.D. NPI 1750383980

NPI Details

DR. Rakesh Rohatgi, M.D. is a medical oncology internal medicine in The Villages, FL with 45 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Rakesh Rohatgi, M.D. NPI is 1750383980. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

1400 N US HIGHWAY 441 STE 540
THE VILLAGES, FL
ZIP 32159-987
Phone: (352) 753-9777
Fax: (866) 446-1888

The NPI 1750383980 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Folic acid level, serum (HCPCS:82746)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Red blood count, manual test (HCPCS:85044)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Red blood count, automated test (HCPCS:85045)
• Vitamin d-3 level (HCPCS:82306)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Protein measurement, serum (HCPCS:84165)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Blood test, clotting time (HCPCS:85610)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Phosphate level (HCPCS:84100)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Magnesium level (HCPCS:83735)
• Injection of drug or substance into vein (HCPCS:96374)
• Automated urinalysis test (HCPCS:81003)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Drawing of blood for a medical problem (HCPCS:99195)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Erythropoietin (protein) level (HCPCS:82668)
• Chemical receptor analysis (HCPCS:84238)
• Testosterone (hormone) level, total (HCPCS:84403)
• Hemoglobin analysis and measurement, electrophoresis (HCPCS:83020)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Hepatitis b core antibody (igm) measurement (HCPCS:86705)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)

The enumeration date for this NPI number is 6/1/2005 and was last updated on 7/9/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.